[10-year experience with using Cavinton in cerebrovascular disorders]

Area of Science:

• Neurology
• Pharmacology
• Vascular Medicine

Background:

• Cerebrovascular diseases encompass a range of conditions affecting brain blood supply.
• Effective management of these conditions is crucial for patient outcomes.
• Cavinton has been utilized in clinical practice for cerebrovascular disease treatment.

Purpose of the Study:

• To evaluate the long-term efficacy and safety of Cavinton in patients with various cerebrovascular diseases.
• To identify patient subgroups and hemodynamic profiles that benefit most from Cavinton treatment.
• To determine contraindications for Cavinton use.

Main Methods:

• A retrospective analysis of 967 patients treated with Cavinton over 10 years.
• Assessment of clinical outcomes including subjective status and specific neurological symptoms.
• Evaluation of cerebral hemodynamics using Rheoencephalography (REG) to correlate with treatment response.

Main Results:

• Significant improvement in subjective status and vestibulocerebellar disorders (75-85%) in early and chronic cerebrovascular conditions like neurocirculatory dystonia and circulatory encephalopathy.
• Faster and more pronounced symptom regression in ischemic stroke patients with an adequate hemodynamic response to Cavinton.
• Less favorable outcomes observed in hypertonic and hypotonic hemodynamic types.
• Identified contraindications including severe hypertensive crises and specific cardiac conditions in elderly patients.

Conclusions:

• Cavinton demonstrates significant therapeutic benefits in early and chronic cerebrovascular diseases.
• Treatment response is influenced by the hemodynamic profile of patients, particularly in ischemic stroke.
• Contraindications must be carefully considered to ensure patient safety.